CoChat

Panic Anxiety, Dyspnea, and Respiratory Disease. Theoretical and Clinical Considerations

Smoller, J W, Pollack, M H, Otto, M W, Rosenbaum, J F, Kradin, R L · 1996 · American journal of respiratory and critical care medicine

The DOI matches its Crossref record, with a small difference in title or year; 7 of the 7 references it cites were found in a registry or an index.

Abstract

There is intriguing evidence suggesting pathophysiologic relationships among dyspnea, hyperventilation, and panic anxiety. The symptoms of panic attacks and pulmonary disease overlap, so that panic anxiety can reflect underlying cardiopulmonary disease and dyspnea can reflect an underlying anxiety disorder. The pathogenesis of panic may be related to respiratory physiology by several mechanisms: the anxiogenic effects of hyperventilation, the catastrophic misinterpretation of respiratory symptoms, and/or a neurobiologic sensitivity to CO2, lactate, or other signals of suffocation. In a subset of patients with PD, incipient pulmonary dysfunction may also contribute to their anxiety symptoms. Patients with pulmonary disease, particularly those with obstructive lung disease, have a high rate of panic symptoms and PD. There is reason to believe that pulmonary disease constitutes a risk factor for the development of panic related to repeated experiences with dyspnea and life-threatening exacerbations of pulmonary dysfunction, repeated episodes of hypercapnia or hyperventilation, the use of anxiogenic medications, and the stress of coping with chronic disease. Panic in pulmonary patients may carry significant morbidity, including phobic avoidance of activity, overly aggressive treatment with anxiogenic medications, and more prolonged and frequent hospitalization. Successful treatment of panic in these patients can improve functional status and quality of life by relieving anxiety and dyspnea. Nonpharmacologic treatment of panic, including cognitive-behavioral approaches, can be useful in patients with concomitant respiratory disease. Sedating medications such as benzodiazepines should be used with caution in patients with pulmonary disease to avoid respiratory depression. Serotonergic antidepressants (SSRIs) and anxiolytics (buspirone) may be effective treatments for panic or generalized anxiety in pulmonary patients and have relatively little potential for significant adverse effects.

Overview

Integrity signals

Registry

Crossref · 10.1164/ajrccm.154.1.8680700

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

The publisher hasn’t deposited this paper’s reference list.

Cited by

See all 270

Metadata

Authors
Smoller, J. W., Pollack, M. H., Otto, M. W., Rosenbaum, J. F., & Kradin, R. L.
Affiliations
McLean Hospital (US)
Venue
American journal of respiratory and critical care medicine
Published
1996-07-01
Volume
154
Issue
1
Pages
6-17
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2081397980
Cited by
270
References
0
Citations by year
2026: 3 · 2025: 5 · 2024: 6 · 2023: 10 · 2022: 13 · 2021: 7 · 2020: 11 · 2019: 7 · 2018: 12 · 2017: 12 · 2016: 8 · 2015: 13 · 2014: 14 · 2013: 6 · 2012: 10
FWCI
10.85
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
panic disorder, dyspnea, hyperventilation, respiratory diseases, obstructive lung disease, panic attacks, catastrophic misinterpretation, hypercapnia, benzodiazepines, respiratory depression, cognitive behavioral therapy, selective serotonin reuptake inhibitors, buspirone, anxiolytic treatment
MeSH terms
Anxiety, Dyspnea, Humans, Lung Diseases, Obstructive, Models, Psychological, Psychotropic Drugs, Respiratory Tract Diseases, Panic Disorder

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Panic Anxiety, Dyspnea, and Respiratory Disease. Theoretical and Clinical Considerations. https://app.cochat.ai/papers/10.1164/ajrccm.154.1.8680700
The paper
Smoller, J. W., Pollack, M. H., Otto, M. W., Rosenbaum, J. F., & Kradin, R. L. (1996). Panic Anxiety, Dyspnea, and Respiratory Disease. Theoretical and Clinical Considerations. American journal of respiratory and critical care medicine. https://doi.org/10.1164/ajrccm.154.1.8680700

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.